Tech Company Financing Transactions
Visterra Funding Round
Polaris Partners joined a $3.5 million venture round for Visterra. The funding round was announced on 3/31/2016.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Undisclosed
Investors
Polaris Partners (Kevin Bitterman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
275 2nd Ave.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Visterra, Inc. is dedicated to the discovery and development of innovative products for the prevention, treatment and diagnosis of infectious diseases. The Company focuses on technologies that can interrogate how pathogens interact with human cells, a critical first step in the disease process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Pereira
Chief Scientific Officer
Zachary Shriver
Vice President
Jean Bender
VP - Administration
Chris Kiefer
VP - Bus. Development
Greg Miller
VP - Finance
Todd Curtis
VP - R & D
Greg Babcock
Browse more venture capital transactions:
Prev: 3/31/2016: Madison Vaccines venture capital transaction
Next: 3/31/2016: Route 92 Medical venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs